Linden Capital Partners has acquired ArtesRx from Flexpoint Ford, completing Flexpoint’s exit from a behavioral health pharmacy platform that expanded from three locations in one state to 16 pharmacies serving patients across 15 states.
Flexpoint established ArtesRx in 2023 alongside Dom Meffe to acquire and scale pharmacies serving patients with complex medication requirements.
During Flexpoint’s ownership, ArtesRx built out its executive team, expanded its sales infrastructure and established an internal M&A operation for complementary acquisitions.
The platform now serves patients with serious mental illness, substance use disorders and intellectual and developmental disabilities.
ArtesRx operates its 16 pharmacies through local brands that maintain existing community and provider relationships.
The exit comes after a combination of organic expansion and acquisitions significantly increased the platform’s geographic reach.
Flexpoint manages approximately $9 billion across private equity and asset opportunities strategies and has completed more than 100 investments since its founding in 2005.
Houlihan Lokey served as financial advisor to ArtesRx.
KEY QUOTES:
“We are incredibly proud of the business and culture we have built at ArtesRx and the impact our team has on the patients and communities we serve.”
Dom Meffe, CEO Of ArtesRx
“Their vision for building a new type of pharmacy platform and their dedication to a care model that puts complex patients first have been key drivers of the Company’s success.”
Michael Fazekas, Managing Director At Flexpoint Ford
